Rapid COJEC versus standard induction therapies for high-risk neuroblastoma.

ABSTRACT:

SUBMITTER: Peinemann F 

PROVIDER: S-EPMC10501324 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature